Fundraising Foxトレジェムバイオファーマ株式会社
京都 (Kyoto), JP · 4 known investors
Find your way into トレジェムバイオファーマ株式会社
Sign up to find every way you can get introduced to トレジェムバイオファーマ株式会社
- Your email: who you already know at トレジェムバイオファーマ株式会社, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the トレジェムバイオファーマ株式会社 team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection. It initially targets patients with congenital tooth agenesis (a rare genetic condition) and ultimately aims to treat tooth loss from decay or periodontal disease.
Founders & leadership
喜ほ
喜早 ほのか (Honoka Kihayashi)代表取締役社長 (Representative Director and President)
髙克
髙橋 克 (Katsu Takahashi)取締役CTO (Director and CTO)
髙宗
髙谷 宗男 (Muneo Takaya)取締役CBO (Director and CBO)
喜ほ
喜早 ほのかCo-founder & CEO (代表取締役社長)
髙克
髙橋 克Co-founder & CTO
髙宗
髙谷 宗男Co-founder & CBO
Investors · 4
Kyoto University Innovation Capitallisted by Kyoto University Innovation CapitalKyoto
How we know: Kyoto University Innovation Capital's portfolio page · Not right? Tell us
Related companies · 1
Companies working in the same space as トレジェムバイオファーマ株式会社.
Frequently asked questions
- What does トレジェムバイオファーマ株式会社 do?
- Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection. It initially targets patients with congenital tooth agenesis (a rare genetic condition) and ultimately aims to treat tooth loss from decay or periodontal disease.
- Who founded トレジェムバイオファーマ株式会社?
- トレジェムバイオファーマ株式会社 was founded by 喜早 ほのか (Honoka Kihayashi), 髙橋 克 (Katsu Takahashi), 髙谷 宗男 (Muneo Takaya), 喜早 ほのか, 髙橋 克, 髙谷 宗男.
- Who are トレジェムバイオファーマ株式会社's investors?
- トレジェムバイオファーマ株式会社's investors include Astellas Venture Management LLC, Kyoto University Innovation Capital, OSAKA University Venture Capital, TOHOKU University Venture Partners.
- Where is トレジェムバイオファーマ株式会社 headquartered?
- トレジェムバイオファーマ株式会社 is headquartered in 京都 (Kyoto), JP.